BMC names their new Board of Directors
by CM Staff
Each board member brings a varying experiences and expertise.
MONTREAL — BMC (Biologics Manufacturing Center Inc) announces the formation of its new Board of Directors. This group of professionals, with their experience leadership, aim to play a role in the future of the organization.
The members of the new Board of Directors are as follows:
Douglas Muzyka
He holds leadership roles in various boards, including Chair of the NRC Council, and serves on boards of Chemtrade Logistics, CCL Industries, Stella-Jones, and Modern Meadow.
Michael May
CEO of CCRM, Michael leads regenerative medicine efforts, seeks partnerships for a therapy facility, and serves on multiple boards, including ExCellThera. He holds a PhD in Chemical Engineering from the University of Toronto.
John Bell
Senior researcher at the Ottawa Hospital Research Institute, John holds a Ph.D. from McMaster University and is a member of the Royal Society of Canada since 2013 as well as of the Canadian Academy of Health Sciences since 2022.
Mark Lievonen
Principal of JML Advisory Services and former president of Sanofi Pasteur Ltd, Mark holds a BBA in Accounting and an MBA from the Schulich School of Business at York University.
Elizabeth Douville
President and CEO of IRICoR, with a Ph.D. in biochemistry from the University of Ottawa, Elizabeth played a key role in developing the early-stage investment model at AmorChem.
Fabien Marino
Vice-President of Central Pharmacy Services at Shoppers Drug Mart, with previous experience as Vice President of the Vaccines Division at Sanofi Canada. Fabien holds three degrees from McGill University in Science and Engineering enrich his background.
Maryse Laliberté
President of MLCaConseils, a company specializing in supporting pharmaceutical and biotechnological businesses for many years, Maryse holds a master’s degree in biochemistry from UQAM.
Andy Sheldon
With experience in various leadership roles in pharmaceutical companies, Andy has reportedly attracted financing as CEO of Medicago. He holds two bachelor’s degrees, one in agricultural sciences and the other in biology.
Each board member brings a varying experiences and expertise. The company hopes this will be invaluable as the organization embarks on new opportunities and challenges.
